Workflow
关于华泰紫金中证医药50指数型发起式证券投资基金可能触发基金合同终止情形的第二次提示性公告

Group 1 - The fund may trigger termination conditions as per the "Fund Contract" if the net asset value falls below 200 million yuan by April 29, 2025 [1] - The fund has a long history of small scale, and if it does not meet the asset threshold by the specified date, it will enter liquidation procedures starting April 30, 2025 [1] - Investors holding fund shares until the completion of the liquidation process will be exempt from all redemption fees [1] Group 2 - The fund will suspend subscription, regular investment, and transfer-in activities starting April 8, 2025 [2] - If termination conditions are met, redemption will be suspended from April 29, 2025, at 15:00, and any redemption requests after this time will not be confirmed [2] - A liquidation team will be established to carry out the fund's asset liquidation process, and investors will be unable to perform any transactions once the liquidation process begins [2] Group 3 - The interpretation rights of this announcement belong to Huatai Securities (Shanghai) Asset Management Co., Ltd. [3]